Form 8-K - Current report:
SEC Accession No. 0001213900-20-004257
Filing Date
2020-02-19
Accepted
2020-02-19 16:18:24
Documents
5
Period of Report
2020-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENTT REPORT f8k021920_citiuspharma.htm 8-K 24432
2 FORM OF INVESTOR WARRANT f8k0220ex4-1_citiuspharma.htm EX-4.1 102320
3 FORM OF PLACEMENT AGENT WARRANT f8k0220ex4-2_citiuspharma.htm EX-4.2 106498
4 FORM OF WARRANT EXERCISE AGREEMENT THE ONE DUBBED SABBY f8k0220ex10-1_citiuspharma.htm EX-10.1 64367
5 FORM OF WARRANT EXERCISE AGREEMENT THE ONE DUBBED ARMISTICE f8k0220ex10-2_citiuspharma.htm EX-10.2 64249
  Complete submission text file 0001213900-20-004257.txt   363242
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 20629960
SIC: 2834 Pharmaceutical Preparations